Clinical Trial Update: A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD) [Phase 4]

View source ↗

Summary

Phase 4 trial update on atorvastatin for high cholesterol in patients at high risk of coronary heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Dyslipidemias

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Dyslipidemias | Phase 4 | Status: COMPLETED